Table 2.

Concentrations/activity of recovery-related blood biomarkers represented as mean ± SD.

Group	Time
	T1					T2
	pre	post	2 h	24 h	48 h	pre	post	2 h	24 h	48 h
CK (U/L)
PLA (n = 23)	135 ± 64	159 ± 69	182 ± 66	346 ± 197	246 ± 123	142 ± 64	161 ± 66	171 ± 64	214 ± 108	207 ± 140
CP (n = 22)	136 ± 65	174 ± 77	204 ± 88	422 ± 225	506 ± 782	125 ± 66	146 ± 74	156 ± 71	192 ± 133	162 ± 103
LDH (U/L)
PLA (n = 21)	165 ± 21	181 ± 24	180 ± 24	174 ± 31	175 ± 35	161 ± 30	176 ± 29	176 ± 29	173 ± 27	178 ± 31
CP (n = 22)	181 ± 20	208 ± 21	204 ± 22	195 ± 24	190 ± 22	175 ± 24	185 ± 24	185 ± 24	182 ± 23	188 ± 26
MYO (ng/ml)
PLA (n = 23)	51 ± 8	89 ± 43	141 ± 108	55 ± 21	49 ± 14	46 ± 9	59 ± 32	77 ± 45	45 ± 13	47 ± 16
CP (n = 21)	48 ± 13	94 ± 50	165 ± 93	62 ± 29	96 ± 120	40 ± 13	46 ± 13	51 ± 14	36 ± 12	35 ± 10
hsCRP (mg/l)
PLA (n = 21)	0.67 ± 0.4	-	-	1.04 ± 1	-	0.61 ± 0.3	-	-	0.55 ± 0.2	-
CP (n = 19)	1.46 ± 1.4	-	-	2.2 ± 1.8	-	1.21 ± 0.9	-	-	1.23 ± 1	-